Evaluation and Management of the Hair Loss Patient in the Primary Care Setting

Ahanogbe, Isabella; Gavino, Alde Carlo P.

doi:10.1016/j.pop.2015.07.005

Cited by 3 publications

(8 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[7][8][9] Screening for metabolic cardiovascular risk factors is useful in patients presenting with patterned hair loss. 3,10…”

Section: Female Pattern Hair Loss and General Healthmentioning

confidence: 99%

“…3 Clinicians should also screen for maladaptive coping mechanisms such as compulsive fixing of one's hair and underlying psychiatric trichotillomania. 1,10,11…”

Section: Psychological Morbiditymentioning

confidence: 99%

“…Generalised and rapid shedding with global hair thinning is unusual and points to other causes such as hyperadrenalism, medication exposure, major stressors or change in hair care practices. 1,3,6,10,11 Hair loss over the temporal region is uncommon in FPHL, compared with male pattern alopecia. If temporal thinning was the first symptom, telogen effluvium, frontal fibrosing alopecia, tractional alopecia and hypothyroidism should be considered.…”

Section: Historymentioning

confidence: 99%

“…2 Figure 2. Summary of counselling points and treatment options 1,2,10,15 • No current treatment will cure the conditiontherefore, avoid paying expensive fees for unproven treatment • The goal of treatment is to prevent further loss of hair, although some individuals may have new hair growth • Clinical effect will take at least 3-6 months' treatment to be noticeable • There may be increased shedding in the first few months of treatment as hairs transition into the growth phase • Treatment needs to be continued daily, and if discontinued, the treatment effect will be lost • Using toothed combs/brushes to allow thin hair to flow through without breakage • Using a friction-free towel that blots moisture without damaging hair • Using hair sprays that are light and non-drying to give volume and prevent breakage Common side effects are lethargy and menorrhagia, which improve after three months. This is a pregnancy category D medication.…”

Section: Androgen-dependent Treatmentsmentioning

confidence: 99%

See 3 more Smart Citations

Female pattern hair loss

Chan¹,

Cook²

2018

Aust J Gen Pract

View full text Add to dashboard Cite

“…[7][8][9] Screening for metabolic cardiovascular risk factors is useful in patients presenting with patterned hair loss. 3,10…”

Section: Female Pattern Hair Loss and General Healthmentioning

confidence: 99%

“…3 Clinicians should also screen for maladaptive coping mechanisms such as compulsive fixing of one's hair and underlying psychiatric trichotillomania. 1,10,11…”

Section: Psychological Morbiditymentioning

confidence: 99%

Section: Historymentioning

confidence: 99%

Section: Androgen-dependent Treatmentsmentioning

confidence: 99%

See 2 more Smart Citations

Female pattern hair loss

Chan¹,

Cook²

2018

Aust J Gen Pract

View full text Add to dashboard Cite

“…Hair loss is a common health problem and represents a diverse group of disorders with different etiologies, as a result of a variety of local and systemic conditions [ 1 ]. The first step in the work-up of alopecia is an early diagnosis through a detailed clinical history and physical examination and appropriate laboratory testing [ 2 , 3 ], to identify the cause. This allows for timely, adequate, and effective treatment and the decision/need for long-term management/follow-up [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

Alopecia and Iron Deficiency: An Interventional Pilot Study in Primary Care to Improve the Request of Ferritin

Salinas

Leiva-Salinas

Flores

et al. 2020

Advances in Hematology

View full text Add to dashboard Cite

Background. The aim was to study the demographic and laboratory pattern of primary care patients with alopecia undergoing laboratory testing, more specifically, the request of hemoglobin and ferritin and values showing anemia and iron deficiency, and to evaluate the effects of an intervention involving automatic ferritin registration and measurement when not requested. Methods. Retrospective and prospective observational cross-sectional studies were conducted, as well as an intervention to automatically register and measure ferritin when not requested by the general practitioner. Results. There were 343 and 1032 primary care laboratory requests prompted by alopecia in the retrospective and prospective studies. Hemoglobin was requested in almost every patient and ferritin in 88%. 5% of the cohort had anemia, and 25% had iron deficiency. The intervention registered and measured that 123 ferritin and 24 iron deficiencies were detected in patients with alopecia, all women, at a cost of 10.6€. Conclusion. Primary care patients with alopecia and laboratory tests request were mainly young female. Our intervention added ferritin when not requested, detecting iron deficiency in 27.9% of women, potentially avoiding the adverse effects of iron deficiency on hair loss.

show abstract

Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia

Alharbi

2022

Journal of Family Medicine and Primary Care

View full text Add to dashboard Cite

Background: Number of reports linked Telogen effluvium to coronavirus disease 2019 (COVID-19) infection. However, data about Telogen effluvium after COVID-19 vaccination are limited. Objectives: To estimate prevalence of Telogen effluvium among those who received COVID-19 vaccination. Methods: A cross-sectional study was performed during July 2021. Adults who received one of recognized COVID-19 vaccine irrespective of previous COVID-19 infection were asked to fill a questionnaire. Results: The majority of participants were females (90.3%). The most common age group was between 21 and 30 years (51.9%). Out of 991 participants who were included in the current analysis, 670 (67.6%) reported post-vaccination hair fall. The probable causes of post-vaccination hair fall were vaccine-related in 185 (27.6%) participants, other causes in 326 (48.7%) participants, and unclear in 326 (48.7%) participants. Post-vaccination hair fall was significantly higher among females compared with males (68.5% versus 57.9%, P = 0.036), those who did not suffer compared with those who suffered from hair fall before vaccination (72.1% versus 63.4%, P = 0.003), and those who did not report compared with those who reported preexisting conditions that might be related to hair fall (74.5% versus 57.3%, P < 0.001). Conclusion: We are reporting a high prevalence of post-vaccination hair fall, which affected approximately two-thirds of participants who received COVID-19 vaccines. Only 28% of these participants were apparently vaccine related. The role of COVID-19 infection and stress caused by infection and vaccine cannot be excluded. Primary care physician and dermatologist need to consider the possibility of COVID-19 vaccine as a potential cause of hair loss.

show abstract

Evaluation and Management of the Hair Loss Patient in the Primary Care Setting

Cited by 3 publications

References 51 publications

Female pattern hair loss

Female pattern hair loss

Alopecia and Iron Deficiency: An Interventional Pilot Study in Primary Care to Improve the Request of Ferritin

Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia

Contact Info

Product

Resources

About